Biomedtech News
Abivax announces excellent results
TRUFFLE CAPITAL & THE INSTITUT PASTEUR CREATE SPIKIMM TO DEVELOP MONOCLONAL ANTIBODIES AS AN INNOVATIVE TREATMENT FOR COVID-19
Holistick raises $5M to boost preclinical development of PFO closure device
Truffle Capital reports outstanding 2020 stock market performance for its listed BioMedTech portfolio companies
Carmat: CE marking for its total artificial heart
Abivax’s Covid-19 Phase 2B/3 MIR-AGE trial with ABX464 declared Research National Priority by the French government’s clinical trial council
Abivax to present at the 39th annual J.P. Morgan Healthcare Conference ahead of major clinical milestones
Discussion of Abivax Clinical Program involving Covid-19, Ulcerative Colitis, Crohn’s Disease and more
Abivax establishes clinical, regulatory and manufacturing framework for ABX464 phase 3 program and potential commercialization in 2021
Centers for Medicare & Medicaid Services (CMS) grant transitional pass-through (TPT) payment for Stryker's SpineJack® System